OptiNose Analyst Ratings
OptiNose Analyst Ratings
While ratings are subjective and will change, the latest OptiNose (OPTN) rating was a maintained with a price target of $4.00 to $3.00. The current price OptiNose (OPTN) is trading at is $1.24, which is out of the analyst's predicted range.| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 08/11/2023 | 141.94% | Piper Sandler | $4 → $3 | Maintains | Overweight |
| 11/14/2022 | 303.23% | BMO Capital | $6 → $5 | Maintains | Outperform |
| 10/21/2022 | 303.23% | Jefferies | → $5 | Assumes | → Buy |
| 03/05/2020 | 1593.55% | Cantor Fitzgerald | $27 → $21 | Reiterates | → Overweight |
| 12/18/2019 | 1916.13% | Cowen & Co. | → $25 | Initiates Coverage On | → Outperform |
| 08/13/2019 | 1835.48% | BMO Capital | $26 → $24 | Maintains | Outperform |
| 11/14/2018 | 2077.42% | Cantor Fitzgerald | $30 → $27 | Maintains | Overweight |
| 08/15/2018 | 2158.06% | BMO Capital | $30 → $28 | Maintains | Outperform |
| 日期 | 上行/下行 | 分析公司 | 目标价格变化 | 评级变化 | 上一次/当前评级 |
|---|---|---|---|---|---|
| 2023年08月11日 | 141.94% | 派珀·桑德勒 | $4→$3 | 维护 | 超重 |
| 2022年11月14日 | 303.23% | 蒙特利尔银行资本 | $6→$5 | 维护 | 跑赢大盘 |
| 2022年10月21日 | 303.23% | 杰富瑞 | →$5 | 假设 | →购买 |
| 03/05/2020 | 1593.55% | 康托·菲茨杰拉德 | $27→$21 | 重申 | →超重 |
| 2019年12月18日 | 1916.13% | 考恩公司 | →$25 | 开始承保 | →跑赢大盘 |
| 2019年08月13日 | 1835.48% | 蒙特利尔银行资本 | $26→$24 | 维护 | 跑赢大盘 |
| 2018年11月14日 | 2077.42% | 康托·菲茨杰拉德 | $30→$27 | 维护 | 超重 |
| 2018年08月15日 | 2158.06% | 蒙特利尔银行资本 | $30→$28 | 维护 | 跑赢大盘 |
What is the target price for OptiNose (OPTN)?
OptiNose的目标价是多少？
The latest price target for OptiNose (NASDAQ: OPTN) was reported by Piper Sandler on August 11, 2023. The analyst firm set a price target for $3.00 expecting OPTN to rise to within 12 months (a possible 141.94% upside). 3 analyst firms have reported ratings in the last year.
派珀·桑德勒于2023年8月11日报道了OptiNose(纳斯达克代码：OPTN)的最新目标价。这家分析公司将目标价定为3美元，预计OPTN将在12个月内上涨至(可能上涨141.94%)。3家分析公司在过去一年公布了评级。
What is the most recent analyst rating for OptiNose (OPTN)?
分析师对OptiNose的最新评级是多少？
The latest analyst rating for OptiNose (NASDAQ: OPTN) was provided by Piper Sandler, and OptiNose maintained their overweight rating.
纳斯达克分析师对OptiNose的最新评级由Piper Sandler提供，OptiNose维持其增持评级。
When is the next analyst rating going to be posted or updated for OptiNose (OPTN)?
OptiNose(OPTN)的下一次分析师评级将于何时发布或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of OptiNose, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for OptiNose was filed on August 11, 2023 so you should expect the next rating to be made available sometime around August 11, 2024.
分析师在进行了广泛的研究后得出了股票评级，其中包括查阅公共财务报表，与OptiNose的高管和客户交谈，以及收听收益电话会议。大多数分析师每三个月就会这样做一次，所以你每年应该会得到每家公司每家公司的4个评级。OptiNose的上一次评级是在2023年8月11日提交的，因此您应该预计下一次评级将在2024年8月11日左右提供。
Is the Analyst Rating OptiNose (OPTN) correct?
分析师评级OptiNose(OPTN)正确吗？
While ratings are subjective and will change, the latest OptiNose (OPTN) rating was a maintained with a price target of $4.00 to $3.00. The current price OptiNose (OPTN) is trading at is $1.24, which is out of the analyst's predicted range.
虽然评级是主观的，并将发生变化，但最新的OptiNose(OPTN)评级维持不变，目标价在4.00美元至3.00美元之间。OptiNose目前的交易价格为1.24美元，超出了分析师的预测区间。
